Peptidyl-histidine modification

pathway activity — cross-omics
GO:0018202Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-histidine modification pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are FAM98B, SPAG7, and CCDC12, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-histidine modification activity versus FAM98B in LSCC (Pearson r = 0.36).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCFAM98B →+0.292+0.055<.001<.00138
OVSPAG7 →+0.331+0.028<.001<.00137
PDACCCDC12 →+0.489+0.044<.001<.00137
OVGLOD4 →+0.504+0.034.001<.00137
OVMETTL16 →+0.300+0.034.003<.00137
HNSCCASP10 →-0.431-0.047<.001.00137
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018202 vs FAM98B — LSCC

Per-sample scatter of Peptidyl-histidine modification activity vs FAM98B in LSCC.

Explore this scatter interactively →

Exploration